The EBV/KSHV Meeting will take place in the Memorial Union on the University of Wisconsin-Madison campus.
*Tentative Agenda – Details Subject to Change*
Saturday, July 28th
| 9:00 AM – 5:00 PM | Satellite Meeting on EBV hydroa vacciniforme
Organized by: Jeffrey Cohen |
Old Madison |
| 12:00 PM – 7:00 PM | Registration | Annex |
| 5:40 PM – 6:00 PM | Welcome & Henle Lecture Introduction | Shannon Hall |
| 6:00 PM | Keynote Address I (Henle Lecture)
Paul Lieberman |
Shannon Hall |
| 7:00 PM | Dinner Reception | Tripp Commons |
Sunday, July 29th
| 8:00 AM – 5:00 PM | Registration | Annex Room |
| 8:00 AM | Coffee | Shannon Hall Lobby |
| 8:45 AM | Welcome & Conference Logistics | Shannon Hall |
| Session 1
9:00 AM – 10:30 AM |
Gene Expression/Epigenetics
Session Chairs: Ke Lan & Wolfgang Hammerschmidt |
Shannon Hall |
| 9:00 AM | Global Changes in the Host B cell During the Pre-latent Phase of EBV Infection
|
Paulina Mrozek-Gorska
|
| 9:15 AM | Single-Cell Analysis of Gammaherpesvirus Infection and Gene Expression
|
Lauren Oko
|
| 9:30 AM | 3D architecture of host-pathogen genomic interactions during EBV reactivation
|
JJ Miranda
|
| 9:45 AM | Modulation of Cellular CpG DNA Methylation by Kaposi’s Sarcoma Associated Herpesvirus
|
Guy Journo
|
| 10:00 AM | Epstein-Barr Virus Nuclear Antigen EBNA-LP is Essential for Transforming Naive B Cells, and Supports the Activation of Viral Genes, but not EBNA2-Induced Cellular genes
|
Rob E. White
|
| 10:15 AM | Polycomb Recruitment During Latency Establishment: A Comparative Study
|
Adam Grundhoff
|
| 10:30 AM – 11:00 AM | Break | Shannon Hall Lobby |
|
Concurrent Sessions |
||
| Session 2A
11:00 AM – 12:30 PM |
Lytic Cycle I
Session Chairs: Linda van Dyk & Mei-Ru Chen |
Shannon Hall |
| 11:00 AM | Continuous DNA Replication Is Required For Late Gene Transcription And Maintenance Of Replication Compartments In Gammaherpesviruses
|
Dajiang Li
|
| 11:15 AM | Intracellular Iron Chelation by a Novel Compound, C7, Induces Lytic Cycle of Epstein-Barr virus (EBV) in EBV-Positive Epithelial Malignancies
|
P.T. Stephanie Yiu
|
| 11:30 AM | Application of the Air Liquid Interface Culture Method to Study EBV Pathogenesis in Polarized Airway Epithelia
|
Kathy Shair
|
| 11:45 AM | NLRX1 Negatively Modulates Type I IFN to Facilitate KSHV Reactivation from Latency
|
Zhe Ma
|
| 12:00 PM | BGLF2 Increases Infectivity of Epstein-Barr virus by Activating AP-1 upon de novo Infection
|
Takayuki Murata
|
| 12:15 PM | The M81 Epstein-Barr virus associated RNA 2 enhances CXCL8 Production and Spontaneous Virus Lytic Replication in Primary B Lymphocytes
|
Zhe Li
|
| Session 2B
11:00 AM – 12:30 PM |
Therapeutics & Vaccines
Session Chairs: Robert Yarchoan & Mu-sheng Zeng |
Play Circle |
| 11:00 AM | Toward the Clinical Development of an EBNA1 Inhibitor for the Treatment of EBV-Associated Nasopharyngeal Carcinoma
|
Troy E. Messick
|
| 11:15 AM | The Unique Structure of the LMP1 – TRAF6 Complex is Critical for Viral Cell Transformation and Serves as Target for Inhibitory Molecules
|
Arnd Kieser
|
| 11:30 AM | CRISPR Resistance Screens Reveal Genetic Mediators of Immunomodulatory Drugs in Primary Effusion Lymphoma
|
Ajinkya Patil
|
| 11:45 AM | Dual Role in Fighting Viral Malignancies: Next Generation Epigenetic Modifier for Viral Gene Activation and Anti-Tumor Immune Response
|
Robert A. Baiocchi
|
| 12:00 PM | Modulating IL-7 Cytokine Receptor Signaling to Enhance the Persistence and Anti-Tumor Efficacy of Epstein-Barr Virus (EBV) Specific T-Cells in EBV Positive Malignancies
|
Sandhya Sharma
|
| 12:15 PM | Spironolactone Blocks EBV Production by Degrading XBP Protein, A Cellular Transcription Factor that Acts as a Cofactor for EBV SM Function
|
Dinesh Verma
|
| 12:30 PM – 2:00 PM | Lunch | Great Hall |
| Session 3
2:00 PM – 4:00 PM |
Virus Host Interactions I
Session Chairs: Mandy Muller & Ben Gewurz |
Shannon Halll |
| 2:00 PM | A Genome-wide Screen of EBV Proteins that Modulate Host SUMOylation Identifies a SUMO E3 Ligase conserved in Herpesviruses
|
Lori Frappier
|
| 2:15 PM | Computational Analysis of Ribonomics Datasets Identifies Long non-coding RNA targets of γ-herpesviral miRNAs
|
Rolf Renne
|
| 2:30 PM | The Receptor or Coreceptors in Epstein-Barr Virus Infection of Nasopharyngeal Epithelial Cells
|
Mu-sheng Zeng
|
| 2:45 PM | Examination of the Effects of Rhesus Macaque Rhadinovirus (RRV) Infection and Viral CD200 (vCD200) on Cellular Gene Expression Profiles During in vivo Infection
|
Ryan D. Estep
|
| 3:00 PM | PIAS1 restricts Epstein-Barr Virus Reactivation and it is Antagonized by Caspases Upon Lytic Induction
|
Renfeng Li
|
| 3:15 PM | Metabolic Reprogramming of Kaposi’s Sarcoma Associated Herpes Virus Infected B-cells in Hypoxia
|
Rajinish K. Singh
|
| 3:30 PM | Caspase 3 Activation Facilitates Lytic Replication of Epstein-Barr Virus in Epithelial Cells
|
Dong-Yan Jin
|
| 3:45 PM | EBNA3A Regulates Apoptosis at Early and Late Times After Infection in Epstein Barr Virus-Infected B Cells
|
Joanne Dai
|
| 4:00 PM – 4:15 PM | Break | Shannon Hall Lobby |
| 4:15 PM | In memoriam | Shannon Hall |
| 4:30 PM | Keynote Address II
Blossom Damania |
Shannon Hall |
| 5:30 PM – 7:00 PM | Dinner | Great Hall |
| 7:00 PM – 9:00 PM | Poster Session I – Wine/Dessert
Odd-Numbered Posters |
Tripp Commons & Main Lounge |
Monday, July 30th
| 7:30 AM- 3:00 PM | Registration | Annex Room |
| 7:30 AM | Coffee | Shannon Hall Lobby |
| Session 4
8:00 AM – 10:00 AM |
Lytic Cycle II
Session Chairs: Fanxiu Zhu & Richard Longnecker |
Shannon Hall |
| 8:00 AM | The EBV Glycoprotein BDLF2 is Essential for the Infection of Stratified Epithelium
|
Ian Hayman
|
| 8:15 AM | Kaposi Sarcoma-Associated Herpesvirus gH Is Essential for Viral Infection, but Not for Virion Assembly or Egress from Cells and is an Ideal Target for Vaccine Development
|
Javier G. Ogembo
|
| 8:30 AM | An Early Lytic Gene Regulates Immediate Early Gene BZLF1
|
Xiaofan Li
|
| 8:45 AM | Immune Mechanisms of Protection Against Latency from Vaccination of a Genetically Engineered Gamma-Herpesvirus
|
Ting-Ting Wu
|
| 9:00 AM | How is EBV’s Genome Amplified during its Lytic Cycle?
|
Thejaswi Nagaraju
|
| 9:15 AM | The Kaposi’s Sarcoma Herpesvirus Non-Structural Membrane Protein pK15 Recruits the Class II PI3K Phosphatidylinositol 4-phosphate 3-kinase C2 alpha to Activate Productive Viral Replication
|
Bizunesh Abere Alamirew
|
| 9:30 AM | CAGE-seq Analysis of Epstein-Barr Virus Lytic Gene Transcription: 3 Kinetic Classes from 2 Mechanisms
|
Reza Djavadian
|
| 9:45 AM | Phosphorylation Regulates the Function of the Epstein-Barr virus Pre-Initiation Complex in Transcription of Late Genes
|
Ayman S. El-Guindy
|
| 10:00 AM – 10:30 AM | Break | Shannon Hall Lobby |
|
Concurrent Sessions |
||
| Session 5A
10:30 AM – 12:00 PM |
Gene Expression II
Session Chairs: Kenneth Kaye & Lori Frappier |
Shannon Hall |
| 10:30 AM | Multiple Roles for EBV microRNAs in Regulating EBV Reactivation
|
Rebecca Skalsky
|
| 10:45 AM | KSHV vIL-6 Intercellular Signaling Increases Integrin Beta 3 Levels and is Dependent on Activated STAT3
|
Ricardo Rivera-Soto
|
| 11:00 AM | Epstein-Barr Virus Nuclear Antigen Leader Protein Co-Activates EP300
|
Chong Wang
|
| 11:15 AM | Epstein Barr Virus (EBV) Latency Gene Expression in Solid Organ (SOT) and Bone Marrow (BMT) Post-transplant Lymphoproliferative Disorders (PTLDs)
|
Amy Chadburn
|
| 11:30 AM | CRISPR-Cas9 Mediated Knockout of Viral ORF57 Gene from All Copies of the KSHV Genome in BCBL-1 Cells
|
Zhi-Ming Zheng
|
| 11:45 AM | The Epstein-Barr Virus BHLF1 Locus Contributes to Viral Latency and B cell Immortalization
|
Lena Lupey-Green
|
| Session 5B
10:30 AM – 12:00 PM |
Epidemiology
Session Chairs: Charles Wood & Alan Chiang |
Play Circle |
| 10:30 AM | Newly Derived endemic Burkitt Lymphoma Cell Lines from Kenyan Patients and the Makings of an Avatar Mouse Model
|
Ann M. Moormann
|
| 10:45 AM | Potential Correlates of Mother to Child Transmission in the Humoral Response to KSHV in Zambia
|
Lisa K. Poppe
|
| 11:00 AM | Genomic Analyses Support the Association of Pathogenic Variants of Epstein-Barr Virus with Nasopharyngeal Carcinoma
|
Alan K.S. Chiang
|
| 11:15 AM | Genome Sequencing Analysis Identifies Epstein-Barr Virus Subtypes Associated with the Risk of Nasopharyngeal Carcinoma
|
Miao Xu
|
| 11:30 AM | The Zp-V3 Variant of the Epstein-Barr Virus BZLF1 Promoter Enhances Lytic Reactivation in Response to B-cell Receptor Stimulation and is Over-represented in Burkitt Lymphomas
|
Jillian A. Bristol
|
| 11:45 AM | Epstein-Barr Virus (EBV) Serological Profile and Hodgkin Lymphoma (HL) Risk
|
Zhiwei Liu
|
| 12:00 PM – 1:00 PM | Lunch | Great Hall |
| 1:00 PM | Keynote Address III
Bettina Kempkes |
Shannon Hall |
| Session 6
2:00 PM – 3:00 PM |
Co-Infections
Session Chairs: Denise Whitby & Christian Münz |
Shannon Hall |
| 2:00 PM | Malaria as a Risk Factor for Early Age of KSHV Infection in a Cohort of Children in Western Kenya
|
Rosemary Rochford
|
| 2:15 PM | KSHV Requires EBV for Infection of Peripheral B Cells
|
Aurélia Faure
|
| 2:30 PM | Tumor Epstein-Barr Virus Status is Prognostic in Primary Effusion Lymphoma
|
Kathryn Lurain
|
| 2:45 PM | Epstein-Barr virus (EBV) Enhances Latent Plasmid Maintenance of Kaposi Sarcoma-associated Herpesvirus (KSHV)
|
Dirk Dittmer
|
| 3:00 PM – 8:00 PM | Optional Excursion + Dinner on Own | |
| 8:00 PM – 10:00 PM | Poster Session II – Beer/Cheese
Even-Numbered Posters |
Tripp Commons & Main Lounge |
Tuesday, July 31st
| 7:30 AM – 5:30 PM | Registration | Annex Room |
| 7:30 AM | Coffee | Shannon Hall Lobby |
| Session 7
8:00 AM – 10:00 AM |
Non-Coding RNAs
Session Chairs: Scott Tibbetts & Erik Flemington |
Shannon Hall |
| 8:00 AM | Misprocessing of Cellular Noncoding RNAs as a Pathway for Cell-Intrinsic Immune Activation
|
John Karijolich
|
| 8:15 AM | Identifying EBV microRNA Targets in B-cell Lymphoma and Gastric Cancer Using CLASH
|
Nathan Ungerleider
|
| 8:30 AM | Transcriptional Regulation of Viral ncRNAs
|
Ashley N. Knox
|
| 8:45 AM | EBV Encoded miR-BART10-3p and miR-BART22 Promote Invasion and Metastasis by Activating Canonical Wnt/β-catenin Signaling Pathway in EBV-Associated Gastric Carcinoma
|
Chun-kui Shao
|
| 9:00 AM | A Herpesvirus Utilizes a Sm-class Non-coding RNAs as a miRNA Adaptor to Modulate Host Gene Expression
|
Demian Cazalla
|
| 9:15 AM | Impact of Demethylating Agents on Nasopharyngeal Carcinoma Xenografts: de novo Expression of Cp/Wp Transcripts and BHRF1 microRNAs
|
Pierre Busson
|
| 9:30 AM | The Secondary Structure of the MHV68 Noncoding RNA TMER4 is Essential for Function at a Critical in vivo Dissemination Bottleneck
|
Brett A. Hoffman
|
| 9:45 AM | Epstein Barr virus circRNAome
|
Erik Flemington
|
| 10:00 AM-10:30 AM | Break | Shannon Hall Lobby |
|
Concurrent Sessions |
||
| Session 8A
10:30 AM – 12:00 PM |
Latency
Session Chairs: Jennifer Totonchy & Maria Masucci |
Shannon Hall |
| 10:30 AM | EBV Persistence without its EBNA3A and 3C Oncogenes in vivo | Anita Murer
|
| 10:45 AM | G-quadruplexes Regulate mRNA Translation of LANA to Control Antigen Presentation during Latency | Prerna Dabral
|
| 11:00 AM | LMP2A Regulates BART miRNAs Transcription by Translational Activation of ETS Family Genes | Hyoji Kim
|
| 11:15 AM | EBV Latency IIb is Phenotypically Distinct from Latency III Independent of LMP1 Expression | Joshua E. Messinger
|
| 11:30 AM | Uracil DNA Glycosylase of Gammaherpesvirus and Mammals Differentially Support Mutational Outcomes | Kevin McBride
|
| 11:45 AM | Successful Short Term Infection of Humanized Mice with EBV Lacking EBNA3 Genes Contrasts Their Essential Role in B Cell Transformation In Vitro and Their Role in Favouring Latency in Memory B Cells | Christine T. Styles
|
| 12:00 PM | Enhancement of in vivo Latency by Substitution of the KSHV LANA DNA Binding Domain with that of MHV68 in Chimeric Virus | Kenneth M. Kaye
|
| 12:15 PM | Identification of ARKL1 as a Jun-interacting Factor that Negatively Regulates EBV Reactivation | Umama Zia Siddiqi
|
| Session 8B
10:30 AM – 12:00 PM |
Virus-Host Interactions II
Session Chairs: Britt Glaunsinger & Yasuaki Harabuchi |
Play Circle |
| 10:30 AM | Role of KSHV in T cell Infiltration in Kaposi’s Sarcoma Microenvironment | Yan Yuan
|
| 10:45 AM | Epstein-Barr virus LMP1 Hijacks the Host ESCRT Machinery for Exosomal Secretion | Dingani Nkosi
|
| 11:00 AM | vIRF-1 Regulates Mitochondrial Content by Promoting Mitophagy during HHV-8 Replication | Mai Tram Vo
|
| 11:15 AM | Epstein-Barr Virus Activates F-box Protein FBXO2 to Limit Viral Infectivity by Targeting Glycoprotein B for Degradation | Lin Feng
|
| 11:30 AM | Cell-Mediated Immune Responses to Persistent KSHV Infection in Mice with Reconstituted Human Immune System Components | Nicole Caduff
|
| 11:45 AM | Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from Cell Cycle | Mark R. Eichelberg
|
| 12:00 PM | IFN-ƴ Responses in Peripheral Blood Lymphocytes of Patients with KSHV-associated Diseases Treated with Pomalidomide and Liposomal Doxorubicin | Kathryn Lurain
|
| 12:15 PM | Epstein-Barr Virus-Infected Tonsillar Marginal Zone B Cells in vivo as a Precursor for Immunosuppression-Related B-cell Lymphoma | Charles Torgbor
|
| 12:30 PM – 1:00 PM | General EBV Association Meeting | Shannon Hall |
| 12:30 PM – 1:30 PM | Lunch | Great Hall |
| Session 9
1:30 PM – 3:00 PM |
Transformation
Session Chairs: Thomas Schulz & Micah Luftig |
Shannon Hall |
| 1:30 PM | Increased Association Between EBV EBNA2 From Type 2 Strains And The Transcriptional Repressor BS69 Restricts B Cell Growth
|
Michelle J. West
|
| 1:45 PM | The Oncogenic Kaposi’s Sarcoma-Associated Herpesvirus Encodes a Mimic of the Tumor Suppressor miR-16
|
Kylee Morrison
|
| 2:00 PM | Role of mTOR Complexes in the Maintenance of Nasopharyngeal Carcinoma Cancer Stem Cells
|
Nannan Zhu
|
| 2:15 PM | An Essential Role of Urea Cycle and Argininosuccinate Synthase 1 in KSHV-induced Cellular Transformation
|
Tingting Li
|
| 2:30 PM | Reverse Engineering EBV Driven B Cell Transformation and Lymphomagenesis in the Mouse
|
Thomas Sommermann
|
| 2:45 Pm | An EBNA3C-deleted Epstein-Barr virus (EBV) Mutant Causes B-cell Lymphomas with Delayed onset in a Cord Blood-Humanized Mouse Model
|
James Romero-Masters
|
| 3:00 PM – 3:30 PM | Break | Shannon Hall Lobby |
|
Concurrent Sessions |
||
| Session 10A
3:30 PM – 5:00 PM |
Immunity & Immune Therapy
Session Chairs: Dirk Dittmer & Rajiv Khanna |
Shannon Hall |
| 3:30 PM | A Role for EBNA2 in Mechanisms that Foster Some Autoimmune Diseases
|
John B. Harley
|
| 3:45 PM | Disruption of IL-15 Signaling and NK cells Facilitates Oncogenesis of Gammaherpesviruses in SIV-Infected Rhesus Macaques
|
Yoshinori Fukazawa
|
| 4:00 PM | Dramatically Decreased and Delayed CD8 T-Cell Responses during Asymptomatic EBV Seroconversion
|
Liisa K. Selin
|
| 4:15 PM | Gammaherpesvirus Infected B Cells Display Abnormal Repertoire
|
Monika Zelazowska
|
| 4:30 PM | Defective EBV Particles equipped with Latent Epitopes offer Increased Protection Against EBV Infection
|
Dwain van Zyl
|
| 4:45 PM | Candidate Public T-Cell Responses to Kaposi sarcoma Identified through T-Cell Receptor Sequencing of Tumor Infiltrating Lymphocytes
|
Warren Phipps
|
| Session 10B
3:30 PM – 5:00 PM |
Virus-Host Interactions II
Session Chairs: Hongyu Deng & Cliona Rooney |
Play Circle |
| 3:30 PM | The KSHV Protein ORF68 is a Proteasome-Manipulating Nuclease Required for DNA Packaging
|
Matthew Gardner
|
| 3:45 PM | Epstein-Barr Virus Nuclear Antigen-1, Action and Reaction as an Oncogene
|
Joanna Wilson
|
| 4:00 PM | Genome-wide Identification of Direct RTA Targets Reveals Key Host Factors for KSHV Lytic Reactivation
|
Bernadett Papp
|
| 4:15 PM | EBV Lytic Replication in mTOR-Inhibited Epithelial Cells is Correlated with YY1 and Mnk1/2 Activities
|
Amy L. Adamson
|
| 4:30 PM | Interferon-Stimulated Gene Product RNF213 Modulates KSHV Lytic Replication and Latency via Targeting RTA
|
Hongyu Deng
|
| 4:45 PM | An Analog Sensitive Derivative of the Epstein Barr Virus v-Cdk Permits the Direct Identification of Substrates Participating in Multiple Stages of Gene Expression
|
Robert F. Kalejta
|
| 5:00 PM – 7:00 PM | Joint Reception of EBV & KSHV Meeting with DNA Tumor Viruses Meeting | Great Hall |
| 7:00 PM | Keynote Address IV
Douglas Lowy |
Shannon Hall |
Wednesday, August 1st
| 8:00 AM – 5:00 PM | Registration | Annex Room |
| 8:00 AM | Coffee | Shannon Hall Lobby |
| Session Topic
9:00 AM – 10:30 AM |
Joint Session #1
Session Chairs: Erle Robertson & Elizabeth White |
Shannon Hall |
| 9:00 AM | Point-of-Care Detection of KSHV and EBV to diagnose Kaposi sarcoma and endemic Burkitt lymphoma
|
Ethel Cesarman
|
| 9:30 AM | The Chemokine CXCL14 Suppresses HPV-positive Head and Neck Cancer through the Antigen-Specific CD8+ T Cell Response
|
Dohun Pyeon
|
| 9:45 AM | Development of a Humanized Mouse Model to Dissect the Role of T-cells in Epstein-Barr Virus Type 2 Latency and Lymphomagenesis
|
Carrie Coleman
|
| 10:00 AM | Repair of E6/E7 induced Breaks in Viral Genomes Leads to Amplification
|
Laimonis Laimins
|
| 10:15 AM | EBV gH/gL nanoparticle vaccines elicit antibodies that potently inhibit EBV glycoprotein-mediated B cell and epithelial cell membrane fusion and neutralize virus infection
|
Jeffrey Cohen
|
| 10:30 AM | Break | Shannon Hall Lobby |
| Session Topic
11:00 AM – 12:30 PM |
Joint Session #2
Session Chairs: Jeffrey Cohen & Miranda Thomas |
Shannon Hall |
| 11:00 AM | Local Dysregulation of the Immune Response Impairs Immunotherapy for HPV Associated Premalignancy
|
Ian Frazer
|
| 11:30 AM | A Novel Virus Counteraction Mechanism against APOBEC3-Mediated Hypermutation and Restriction
|
Adam Cheng
|
| 11:45 AM | Apobec3A is a Novel Restriction Factor Antagonizing Efficient HAdV Replication
|
Julia Mai
|
| 12:00 PM | The Enzymatic Activities of the Viral dUTPase and Viral uracil-DNA Glycosylase Stabilize the Gammaherpesvirus Genome and Promote Pathogenesis in the Host
|
Laurie Krug
|
| 12:15 PM | Epstein-Barr Virus Deubiquitinase BPLF1 Targets the RIG-I Signalosome to Inhibit the IFN Response
|
Maria G. Masucci
|
| 12:30 PM – 2:00 PM | Lunch | Great Hall |
| August 1 | Wednesday Afternoon | |
| Session Topic
2:00 PM – 3:30 PM |
Joint Session #3
Session Chairs: Michelle West & Doug Lowy |
Shannon Hall |
| 2:00 PM | EBV-Induced Metabolic Dependency Factors in B-cell Transformation
|
Ben Gewurz
|
| 2:30 PM | Identifying Genome-Wide Targets of the Late Gene Transcription Complex in KSHV
|
Divya Nandakumar
|
| 2:45 PM | High Risk a-HPV Oncogenes Induce and Disrupt Tranlesion Synthesis
|
Sebastian Wendel
|
| 3:00 PM | High Risk HPV Oncogenes Impair the Fanconi Anemia DNA Repair Pathway
|
Sujita Khanal
|
| 3:15 PM | Structure-Guided Identification of Interaction Hotspot for Developing Inhibitors Interrupting KSHV Capsid Assembly
|
Danyang Gong
|
| 3:30 PM | Break | Shannon Hall Lobby |
| Session Topic
4:00 PM – 5:30 PM |
Joint Session #4
Session Chairs: Laurie Krug & Bettie Steinberg |
Shannon Hall |
| 4:00 PM | Discovery and characterization of human γ-Herpesvirus-circular RNAs
|
Tuna Toptan
|
| 4:15 PM | Human and Viral Circular RNAs during Infection
|
Takanobu Tagawa
|
| 4:30 PM | High-Risk HPV E7 Proteins Degrade the Tumor Suppressor PTPN14 to Limit Keratinocyte Differentiation
|
Elizabeth White
|
| 4:45 PM | Human Papillomavirus E7 Oncoprotein Promotes the Epstein-Barr Virus Lytic Life Cycle in Immortalized Oral Keratinocytes
|
Kathleen Makielski
|
| 5:00 PM | Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes
|
Joseph Guidry
|
| 5:15 PM | EBV Hijacks PARP1 Activity to Control Both the Viral and Cellular Epigenome
|
Italo Tempera
|
| 6:00 PM – 9:00 PM | Closing Banquet | Great Hall |
| 9:00 PM – 11:00 PM | Dance | Great Hall |
Key Note Speakers
Blossom Damania, Ph.D.
University of North Carolina Chapel Hill
Bettina Kempkes, Prof. Dr.
Helmholtz Center Munich
Paul M. Lieberman, Ph.D.
The Wistar Institute
Doug Lowy, M.D.
Center for Cancer Research
National Cancer Institute